Loading...
•
Jun 30, 2024
OptimizeRx Q2 2024 Earnings Report
Reported Q2 2024 financial results with revenue increasing year-over-year.
Key Takeaways
OptimizeRx reported Q2 2024 revenue of $18.8 million, a 36% increase year-over-year. Gross profit increased by 50% to $11.7 million, with a gross margin of 62%. The company reiterated its full-year 2024 revenue guidance of at least $100 million and adjusted EBITDA of at least $11 million.
Q2 revenue reached $18.8 million, a 36% increase year-over-year.
Q2 gross profit increased 50% year-over-year to $11.7 million, with a gross margin of 62%.
The company won 8 DAAP deals during Q2.
Full year 2024 revenue is expected to be at least $100 million.
Forward Guidance
For the full year 2024, the Company is reiterating its 2024 guidance and expects revenue to be at least $100 million with an Adjusted EBITDA of at least $11 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...